Barbara Monti

Via Selmi 3
Bologna, 40126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation.

A Dual Approach To Combat Alzheimer's Disease through Concomitant hBChE Inhibition and S1R Activation.

Journal: ACS chemical neuroscience

Published: January 27, 2026

Total Syntheses of the Amaryllidaceae Alkaloids Carltonines A-C and the Neuroprotective and Immunomodulatory Evaluation of Carltonine B.

Total Syntheses of the Amaryllidaceae Alkaloids Carltonines A-C and the Neuroprotective and Immunomodulatory Evaluation of Carltonine B.

Journal: Journal of natural products

Published: October 09, 2025

Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.

Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.

Journal: Cell death & disease

Published: September 08, 2025

Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors.

Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based Inhibitors.

Journal: Journal of medicinal chemistry

Published: August 08, 2025

Vitamin K-Trolox synergism realized in hybrid neuroprotectant with potent anti-ferroptosi/oxytosis activity, reduced toxicity, and in vivo efficacy in Alzheimer's disease mouse model.

Vitamin K-Trolox synergism realized in hybrid neuroprotectant with potent anti-ferroptosi/oxytosis activity, reduced toxicity, and in vivo efficacy in Alzheimer's disease mouse model.

Journal: European journal of medicinal chemistry

Published: June 30, 2025

Isofagomine-coumarin hybrids: bridging cancer and Alzheimer's disease.

Isofagomine-coumarin hybrids: bridging cancer and Alzheimer's disease.

Journal: Chemico-biological interactions

Published: May 17, 2025

Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease.

Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: May 11, 2025

Interplay between circadian rhythms and epigenetics in neural stem cells and Alzheimer's disease.

Interplay between circadian rhythms and epigenetics in neural stem cells and Alzheimer's disease.

Journal: Progress in neurobiology

Published: April 10, 2025

Exploiting acylaminopyrazole scaffold for polypharmacology approach in Alzheimer's disease.

Exploiting acylaminopyrazole scaffold for polypharmacology approach in Alzheimer's disease.

Journal: European journal of medicinal chemistry

Published: March 19, 2025

Author Correction: Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR.

Author Correction: Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR.

Journal: Scientific reports

Published: January 28, 2025

Unveiling the antitumor mechanism of 7α-acetoxy-6β-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma.

Unveiling the antitumor mechanism of 7α-acetoxy-6β-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma.

Journal: Journal of ethnopharmacology

Published: June 12, 2024

The mitochondrial aspartate/glutamate carrier does not transport GABA.

The mitochondrial aspartate/glutamate carrier does not transport GABA.

Journal: Biochimica et biophysica acta. Bioenergetics

Published: April 30, 2024

Showing 1-12 of 69

Last Updated: 09/26/2026